Literature DB >> 7568176

The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68.

M P Ramprasad1, W Fischer, J L Witztum, G R Sambrano, O Quehenberger, D Steinberg.   

Abstract

We have previously reported the partial purification of a 94- to 97-kDa plasma membrane protein from mouse peritoneal macrophages that binds oxidatively modified low density lipoprotein (OxLDL) and phosphatidylserine-rich liposomes. We have now identified that protein as macrosialin, a previously cloned macrophage-restricted membrane protein in the lysosomal-associated membrane protein family (mouse homologue of human CD68). Early in the course of purification of the 94- to 97-kDa protein, a new OxLDL-binding band at 190-200 kDa appeared and copurified with the 94- to 97-kDa protein. The HPLC pattern of tryptic peptides from this higher molecular mass ligand-binding band closely matched that derived from the 94- to 97-kDa band. Specifically, the same three macrosialin-derived tryptic peptides (9, 9, and 15 residues) were present in the purified 94- to 97-kDa band and in the 190- to 200-kDa band and antisera raised against peptide sequences in macrosialin recognized both bands. An antiserum against macrosialin precipitated most of the 94- to 97-kDa OxLDL-binding material. We conclude that the binding of OxLDL to mouse macrophage membranes is in part attributable to macrosialin. Our previous studies show that OxLDL competes with oxidized red blood cells and with apoptotic thymocytes for binding to mouse peritoneal macrophages. Whether macrosialin plays a role in recognition of OxLDL and oxidatively damaged cells by intact macrophages remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568176      PMCID: PMC40845          DOI: 10.1073/pnas.92.21.9580

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils.

Authors:  T Kodama; M Freeman; L Rohrer; J Zabrecky; P Matsudaira; M Krieger
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

3.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

4.  A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein.

Authors:  C P Sparrow; S Parthasarathy; D Steinberg
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

5.  Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins.

Authors:  H Arai; T Kita; M Yokode; S Narumiya; C Kawai
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Enhanced macrophage degradation of biologically modified low density lipoprotein.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Arteriosclerosis       Date:  1983 Mar-Apr

8.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

Authors:  U P Steinbrecher; S Parthasarathy; D S Leake; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Differential expression of membrane sialoglycoproteins in exudate and resident mouse peritoneal macrophages.

Authors:  S Rabinowitz; S Gordon
Journal:  J Cell Sci       Date:  1989-08       Impact factor: 5.285

10.  Differential expression of murine macrophage surface glycoprotein antigens in intracellular membranes.

Authors:  M J Smith; G L Koch
Journal:  J Cell Sci       Date:  1987-02       Impact factor: 5.285

View more
  53 in total

1.  Macrophages lacking scavenger receptor A show a decrease in binding and uptake of acetylated low-density lipoprotein and of apoptotic thymocytes, but not of oxidatively damaged red blood cells.

Authors:  V Terpstra; N Kondratenko; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Characterization of plasmid DNA binding and uptake by peritoneal macrophages from class A scavenger receptor knockout mice.

Authors:  Y Takakura; T Takagi; M Hashiguchi; M Nishikawa; F Yamashita; T Doi; T Imanishi; H Suzuki; T Kodama; M Hashida
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

Review 3.  Macrophage-specific gene expression: current paradigms and future challenges.

Authors:  David R Greaves; Siamon Gordon
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

Review 4.  Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement.

Authors:  S P Hart; J R Smith; I Dransfield
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

5.  Identification and characterization of class B scavenger receptor CD36 from the hard tick, Haemaphysalis longicornis.

Authors:  Kyaw Min Aung; Damdinsuren Boldbaatar; Min Liao; Rika Umemiya-Shirafuji; Sumihiro Nakao; Terushige Matsuoka; Tetsuya Tanaka; Kozo Fujisaki
Journal:  Parasitol Res       Date:  2010-09-25       Impact factor: 2.289

6.  Phagocytic clearance of apoptotic cells: role in lung disease.

Authors:  Jeong H Yun; Peter M Henson; Rubin M Tuder
Journal:  Expert Rev Respir Med       Date:  2008-12       Impact factor: 3.772

Review 7.  Atherosclerosis in autoimmune diseases.

Authors:  Eiji Matsuura; Kazuko Kobayashi; Luis R Lopez
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

8.  beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin.

Authors:  S K Moestrup; I Schousboe; C Jacobsen; J R Leheste; E I Christensen; T E Willnow
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Sulfated glycosphingolipid as mediator of phagocytosis: SM4s enhances apoptotic cell clearance and modulates macrophage activity.

Authors:  Zoran V Popovic; Roger Sandhoff; Tjeerd P Sijmonsma; Sylvia Kaden; Richard Jennemann; Eva Kiss; Edgar Tone; Frank Autschbach; Nick Platt; Ernst Malle; Hermann-Josef Gröne
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

Review 10.  Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome.

Authors:  Paul R J Ames; Annamaria Margarita; Jose Delgado Alves
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.